Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting

Journal of Human Hypertension

Volumn 20, Issue 7, 2006, Pages 543-545

  Jani, B ^a   Bulpitt, C J ^a   Rajkumar, C ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIHYPERTENSIVE AGENT; DIGOXIN;

ACCURACY; ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HOLTER MONITORING; HUMAN; HYPERTENSION; MALE; SPHYGMOMANOMETER; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

AGED; ATRIAL FIBRILLATION; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORS; HUMANS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SPHYGMOMANOMETERS;

EID: 33745234213     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002016     Document Type: Article

References (11)

1. Beevers G, Lip GYH, O'Brien E. ABC of Hypertension. Clinical Review. Blood Pressure measurement. Part 2 conventional sphygmomanometry: Technique of auscultatory blood pressure measurement. B Med J 2001; 322: 1043-1047.
2. Imai Y, Munakata M, Tsuji I, Ohkubo T, Satoh H, Yoshino H et al. Seasonal variation in blood pressure in normotensive women studied by home measurements. Clin Science 1996; 90: 550-560.
3. Jones DW, Apple LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately new and persistent challenges. JAMA 2003; 289(8): 1027-1030.
4. O'Brien E, Waeber B, Parati G, Staessen G, Myers MG. Blood pressure measuring devices: Recommendations of the European society of hypertension. BMJ 2001; 322: 531-536.
5. Stewart MJ, Gough K, Padfield PL. The accuracy of automated blood pressure measuring device in patients with controlled atrial fibrillation. J Hypertens 1995; 13: 297-300.
6. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004; 110(9): 1042-1046.
7. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96(7): 2455-2461.
8. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285(22): 2864-2870.
9. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation. J Am Coll Cardiol 1997; 30: 1024-1039.
10. Sykes D, Dewar R, Mohanaruban K, Donovan K, Nicklason F, Thomas DM et al. Measuring blood pressure in the elderly: Does atrial fibrillation increase observer variability? Br Med J 1990; 300: 162-163.
11. Takahashi N, Ishibashi Y, Shimada T, Sakane T, Ohata S, Sugamori T et al. Impaired exercise-induced vasodilatation in chronic atrial fibrillation-role of endothelium - derived nitric oxide. Circ J 2002; 66: 583-588.